Creation of a Longitudinal Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)


About this study

To develop a repository of blood, urine and tissue samples from patients with ILD to support future studies into the development of such biomarkers.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

Inclusion Criteria:

  • Patients with a diagnosis of ILD or any fibrotic disease of the lung
  • Patients willing to provide written informed consent

Exclusion Criteria:

  • Unwillingness/unable to give blood and urine samples

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Eva Carmona Porquera, M.D., Ph.D.

Open for enrollment

Contact information:

Boleyn Andrist CCRP


More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer